These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2972886)

  • 1. Long-term treatment of severe dysarthria: a case study.
    Simpson MB; Till JA; Goff AM
    J Speech Hear Disord; 1988 Nov; 53(4):433-40. PubMed ID: 2972886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAF as instrumental treatment for dysarthria in progressive supranuclear palsy: a case report.
    Hanson WR; Metter EJ
    J Speech Hear Disord; 1980 May; 45(2):268-76. PubMed ID: 6449631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of rate control on the intelligibility and naturalness of dysarthric speech.
    Yorkston KM; Hammen VL; Beukelman DR; Traynor CD
    J Speech Hear Disord; 1990 Aug; 55(3):550-60. PubMed ID: 2381196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxic dysarthria: treatment sequences based on intelligibility and prosodic considerations.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Nov; 46(4):398-404. PubMed ID: 7300267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing speech supplementation strategies: effects on intelligibility and speech rate of individuals with chronic severe dysarthria.
    Hustad KC; Jones T; Dailey S
    J Speech Lang Hear Res; 2003 Apr; 46(2):462-74. PubMed ID: 14700386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microcomputer-based wearable biofeedback device to improve transfer of treatment in parkinsonian dysarthria.
    Rubow R; Swift E
    J Speech Hear Disord; 1985 May; 50(2):178-85. PubMed ID: 3990263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of hemifacial spasm and dysarthria following EMG biofeedback.
    Rubow RT; Rosenbek JC; Collins MJ; Celesia GG
    J Speech Hear Disord; 1984 Feb; 49(1):26-33. PubMed ID: 6545665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phonation therapy approach for Mandarin-English bilingual clients with dysarthria.
    Lee T; McCann C
    Clin Linguist Phon; 2009 Oct; 23(10):762-79. PubMed ID: 19883186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Speech disorders in Parkinson patients].
    Kerschan K; Pankl W; Auff E
    Wien Klin Wochenschr; 1998 Apr; 110(8):279-86. PubMed ID: 9615959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor speech impairment in a case of childhood basilar artery stroke: treatment directions derived from physiological and perceptual assessment.
    Horton SK; Murdoch BE; Theodoros DG; Thompson EC
    Pediatr Rehabil; 1997; 1(3):163-77. PubMed ID: 9689252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of smooth speech on the speech production of an individual with ataxic dysarthria.
    Stocks R; Dacakis G; Phyland D; Rose M
    Brain Inj; 2009 Sep; 23(10):820-9. PubMed ID: 19697171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rate control on speech production and intelligibility in dysarthria.
    Van Nuffelen G; De Bodt M; Vanderwegen J; Van de Heyning P; Wuyts F
    Folia Phoniatr Logop; 2010; 62(3):110-9. PubMed ID: 20424466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the needs of speakers with longstanding dysarthria: computerized and traditional therapy compared.
    Palmer R; Enderby P; Hawley M
    Int J Lang Commun Disord; 2007 Mar; 42 Suppl 1():61-79. PubMed ID: 17454237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electropalatography treatment for articulation impairment in children with dysarthria post-traumatic brain injury.
    Morgan A; Liegeois F; Occomore L
    Brain Inj; 2007 Oct; 21(11):1183-93. PubMed ID: 17896211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient selection profile for the use of speech prostheses in adult dysarthria.
    Bedwinek AP; O'Brien RL
    J Commun Disord; 1985 Jun; 18(3):169-82. PubMed ID: 3891798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audiological rehabilitation of patients with brainstem disorders.
    Fourcin AJ; Stephens SD; Hazan V; Irwin J; Ball V; Delmont J
    Br J Audiol; 1985 Feb; 19(1):29-42. PubMed ID: 3159456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.